Fidelity Disrupt Medicin ETFFMEDETF
13F holders, Q1 2025 (March 31)6holders −2
0new positions
2sold out
$23.61avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Fidelity Disrupt Medicin ETF (FMED) in their 13F filings, down 2 from Q4 2024. 0 opened new positions and 2 sold out. The largest holders were FMR LLC ($15.1M), Wealth Enhancement Advisory Services, LLC ($14.5M) and Jane Street Group, LLC ($1.6M).
- Company
- Fidelity Disrupt Medicin ETF
- CUSIP
- 316092147
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $9K |
All 13F filers, Q4 2024 → Q1 2025: 29,096 shares bought and 22,948 shares sold, net +6,148 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| FMR LLC | 0.00% | Reduce -3.4% | 637,788 | $15.1M |
| Wealth Enhancement Advisory Services, LLC | 0.03% | Add +4.9% | 612,212 | $14.5M |
| Jane Street Group, LLC | 0.00% | Add +0.8% | 66,382 | $1.6M |
| Park Square Financial Group, LLC | 0.01% | No change | 589 | $14K |
| Central Pacific Bank - Trust Division | 0.00% | No change | 97 | $2K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 90 | $2K |
"% of holder's portfolio" is FMED's weight in each manager's 13F, not the share of Fidelity Disrupt Medicin ETF the manager owns.